טוען...
Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer
Men with prostate cancer face difficult choices when selecting a therapy for localized prostate cancer. Comparative data from controlled studies are lacking and clinical opinions diverge about the benefits and harms of treatment options. Consequently, there is limited guidance for patients regarding...
שמור ב:
| הוצא לאור ב: | Am J Prev Med |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4733621/ https://ncbi.nlm.nih.gov/pubmed/26590643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2015.08.016 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|